Certara’s Vaccine Simulator Tool Effective in Predicting Timing of COVID-19 Vaccines

September 15, 2021

A recent study confirmed Certara findings regarding the interval between COVID-19 vaccine doses. Researchers are also using its Vaccine Simulator tool to understand the efficacy of COVID-19 booster shots and whether vaccines from different manufacturers can be mixed.

Certara CEO William F. Feehery remarks, “The Pitch study results further validate that Certara’s biosimulation technology is a powerful, predictive tool to understand how vaccines and COVID-19 therapies work, enabling us to get dosing regimens right the first time,” adding, “We continue to invest in innovation to fight this ongoing pandemic and benefit global health.” Read more here.

(Source: 7/23/21)

Share This Story!